Stay updated on THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial

Sign up to get notified when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    THALES study page NCT03354429 shows the same core content as before, with no changes to primary outcomes, eligibility criteria, enrollment, or dates. The differences appear to be minor formatting/layout adjustments.
    Difference
    0.1%
    Check dated 2025-10-28T05:24:30.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page is updated to reflect a new version (v3.2.0) and to add a prominent notice about government funding lapse and current operating status of NIH Clinical Center; the previous version reference (v3.1.0) was removed.
    Difference
    2%
    Check dated 2025-10-06T16:04:18.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page now shows a newer version (v3.1.0) and removes several drug-safety topics, narrowing content coverage without adding new material elsewhere.
    Difference
    0.2%
    Check dated 2025-09-29T09:58:21.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    México replaces Mexico (01090) and the revision becomes v3.0.2; Back to Top removed (minor UI change).
    Difference
    0.3%
    Check dated 2025-09-15T00:28:48.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T20:52:21.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of numerous locations and facility names, particularly in South Korea, Russia, and various European countries. Additionally, the study's total number of locations has been revised from 388 to 387.
    Difference
    23%
    Check dated 2025-08-31T12:57:34.000Z thumbnail image

Stay in the know with updates to THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial

Enter your email address, and we'll notify you when there's something new on the THALES: TicAgrelor & ASA in Acute Stroke Clinical Trial page.